Quantitative Assessment of Tissue Biomarkers and Construction of a Model to Predict Outcome in Breast Cancer Using Multiple Imputation by John W. Emerson, Marisa Dolled-Filhart, Lyndsay Harris, David L. Rimm, David P. Tuck

Get full text

Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer by Daniel E. Carvajal-Hausdorf, Nikita Mani, Vamsidhar Velcheti, Kurt A. Schalper, David L. Rimm

Get full text

Quantitative Assessment of Tissue Biomarkers and Construction of a Model to Predict Outcome in Breast Cancer Using Multiple Imputation by John W. Emerson, Marisa Dolled-Filhart, Lyndsay Harris, David L. Rimm, David P. Tuck

Get full text

Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization by Jason A. Hanna, Hallie Wimberly, Salil Kumar, Frank Slack, Seema Agarwal, David L. Rimm

Get full text

Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method. by Yalai Bai, Huan Cheng, Jennifer Bordeaux, Veronique Neumeister, Sudha Kumar, David L Rimm, David F Stern

Get full text

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC) by Daniel Carvajal-Hausdorf, Mehmet Altan, Vamsidhar Velcheti, Scott N. Gettinger, Roy S. Herbst, David L. Rimm, Kurt A. Schalper

Get full text

Antibody validation for protein expression on tissue slides: a protocol for immunohistochemistry by Tyler MacNeil, Ioannis A Vathiotis, Sandra Martinez-Morilla, Vesal Yaghoobi, Jon Zugazagoitia, Yuting Liu, David L Rimm

Get full text

High SOX2 levels predict better outcome in non-small cell lung carcinomas. by Vamsidhar Velcheti, Kurt Schalper, Xiaopan Yao, Huan Cheng, Mehmet Kocoglu, Kavita Dhodapkar, Yanhong Deng, Scott Gettinger, David L Rimm

Get full text

Antibody validation by Jennifer Bordeaux, Allison W. Welsh, Seema Agarwal, Elizabeth Killiam, Maria T. Baquero, Jason A. Hanna, Valsamo K. Anagnostou, David L. Rimm

Get full text

Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers by Brian Alexander, Lajos Pusztai, David L Rimm, Priti Hegde, Mariya Rozenblit, Richard Huang, Natalie Danziger, Shakti Ramkissoon, Kim Blenman, Jeffrey S Ross

Get full text

BCAM (basal cell adhesion molecule) protein expression in different tumor populations by Sneha Burela, Mengni He, Ioannis P. Trontzas, Niki Gavrielatou, Kurt A. Schalper, Solomon Langermann, Dallas B. Flies, David L. Rimm, Thazin N. Aung

Get full text

The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?Research in context by Joan Martínez Vidal, Nikos Tsiknakis, Johan Staaf, Ana Bosch, Anna Ehinger, Emma Nimeus, Roberto Salgado, Yalai Bai, David L. Rimm, Johan Hartman, Balazs Acs

Get full text

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance by David A. Schoenfeld, Ross D. Merkin, Myrto Moutafi, Sandra Martinez, Adebowale Adeniran, Deepika Kumar, Lucia Jilaveanu, Michael Hurwitz, David L. Rimm, Harriet M. Kluger

Get full text

Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance by Vasiliki Pelekanou, Daniel E. Carvajal-Hausdorf, Mehmet Altan, Brad Wasserman, Cristobal Carvajal-Hausdorf, Hallie Wimberly, Jason Brown, Donald Lannin, Lajos Pusztai, David L. Rimm

Get full text

Erratum to: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance by Vasiliki Pelekanou, Daniel E. Carvajal-Hausdorf, Mehmet Altan, Brad Wasserman, Cristobal Carvajal-Hausdorf, Hallie Wimberly, Jason Brown, Donald Lannin, Lajos Pusztai, David L. Rimm

Get full text

Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review by Taja Lozar, Wei Wang, Niki Gavrielatou, Leslie Christensen, Paul F. Lambert, Paul M. Harari, David L. Rimm, Barbara Burtness, Cvetka Grasic Kuhar, Evie H. Carchman

Get full text

[Letter to the Editor] The need for improved education and training in research antibody usage and validation practices by Leonard P. Freedman, Mark C. Gibson, Andrew R.M. Bradbury, Arthur M. Buchberg, Darryl Davis, Marisa P. Dolled-Filhart, Fridtjof Lund-Johansen, David L. Rimm

Get full text

Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modality by Ioannis A. Vathiotis, Zhi Yang, Jason Reeves, Maria Toki, Thazin Nwe Aung, Pok Fai Wong, Harriet Kluger, Konstantinos N. Syrigos, Sarah Warren, David L. Rimm

Get full text

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC. by Diego Alvarado, Gwenda F Ligon, Jay S Lillquist, Scott B Seibel, Gerald Wallweber, Veronique M Neumeister, David L Rimm, Gerald McMahon, Theresa M LaVallee

Get full text

Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen. by Jennifer M Bordeaux, Huan Cheng, Allison W Welsh, Bruce G Haffty, Donald R Lannin, Xingyong Wu, Nan Su, Xiao-Jun Ma, Yuling Luo, David L Rimm

Get full text